BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017

Similar documents
UK Biobank Past, Present, and Future

Finnish Biobanks. The most advanced testbed in the world

Topic: Genome-Environment Interactions in Inflammatory Skin Disease

Expert Centres for Improved Access to Research Infrastructures

Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

The Swedish Twin registry

All research lines at the LMU have a strong methodological focus

Research Powered by Agilent s GeneSpring

Our website:

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health

MRC Stratified Medicine Initiative

IMI: Accelerated Drug Portal. Julia Brosnan on behalf of Innovative Medicines Initiative

NGS-based innovations within the Leiden Network

Nordic Register and Biobank Data

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

~1O % of the population = 500,000 Finns

1.0 Background to the organisation

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure

The International Mouse Phenotyping Consortium (IMPC)

A framework for quality management in the biomedical research infrastructures (BMS RIs)

SPECTArare as an innovative model of combining clinical research and care in an ERN. Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland

HLA and other tales: The different perspectives of Celiac Disease Gutierrez Achury, Henry Javier

European priorities in health research

A Gateway for Health: BBMRI and Africa Prof. Jan-Eric Litton Director General BBMRI-ERIC

Coordinated Research Infrastructures Building Enduring Life science services

Innovative Medicines Initiative Sadallah Fatiha IMI JU Office, Brussels, Belgium

Biobanks in Spain. An overview.

AIT - Austrian Institute of Technology

Multi-omics analysis powered by massive data integration

Arto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF

Amendment of the Work Programme 2017 version 1

BBMRI.at. Biobanking and BioMolecular resources Research Infrastructure Austria

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University

The EORTC Molecular Screening programme SPECTA

Clinical and Translational Bioinformatics

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013

Interpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI

BBMRI.at. Biobanking and BioMolecular resources Research Infrastructure Austria

elin grundberg JULY 2018 JK - PRESENTATION- 11 MINS [MIXED RESPONDENTS] [Other comments:]

PARTNERS PARTNERS. Beyond the Barrier. Network in the biomedical Ecosystem and Robust Support system

Supplementary Materials for

Genomics and Proteomics *

Biobanks for biomedical research

University of Eastern Finland (UEF) Main Research Lines

TraIT Foundation - governance in cloud applications

Resources Available through the Albert Einstein College of Medicine Nathan Shock Center

Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls

leading the way in research & development

Capabilities & Services

Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls

Personalized Medicine

Galaxy and transmart in data management in translational research

Genomic solutions for complex disease

Toward a Systems Science Approach to Eliminating Health Disparities in Indigenous Populations

All of Us Research Program

IBBL: Introduction to Biobanks and their services

Computational Challenges in Life Sciences Research Infrastructures

LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE

PRELIMINARY AGENDA. Maarten J. IJzerman, PhD, Professor and Chair of Cancer Health Services Research

Real World Evidence in High Definition Unlocking Population Cohorts as Infrastructure for Innovative Product Development

US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office

LETI-HEALTH. Adrienne Pervès Deputy Director LETI Technologies for Biology and healthcare Department

BIG DATA: from the Moli-sani project to the Neuromed integrated health platform and Biobank

Overview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017

TraIT Multimodal data management

Missions of ToMMo Supercomputer System

The Age of Personalised Medicine Are We Ready?

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

How European RIs can boost Open Science & Open Innovation

Promise and Pitfalls of MicrobiomeModulating Methods for Inflammatory

Examples of best practices for capacity building in Africa. Dr Maimuna Mendy, Head LSB Group (LSB/DIR) ibb.iarc.fr bcnet.iarc.

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

The Innovative Medicines Initiative Europe s partnership for health. Tek-Ang LIM, 20 June 2018, Brussels

Exposome: Challenges and Opportunities in the study of NCDs

A whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger

Advancing Life Sciences

Introduction to Add Health GWAS Data Part I. Christy Avery Department of Epidemiology University of North Carolina at Chapel Hill

Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017

Data Mining for Genomic- Phenomic Correlations

Clinical research in Southampton

LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES

Genetics and Bioinformatics

UNITING AGRICULTURE AND MEDICINE. Director, Nebraska Food for Health Center

DNA. Clinical Trials. Research RNA. Custom. Reports CLIA CAP GCP. Tumor Genomic Profiling Services for Clinical Trials

University of Bristol - Explore Bristol Research. Peer reviewed version. Link to published version (if available): /

The HUNT Study and potential for innovation and industry research collaboration

Jefferies Healthcare Conference. Frank Witney, President & CEO

Each series will contain separately published parts under the generic specimen type according to specific methods.

Perspectives on the Priorities for Bioinformatics Education in the 21 st Century

Optimising Clinical Laboratory Operations. Alan Brown SLAS Compound Management March 2017

- OMICS IN PERSONALISED MEDICINE

Basic principles of NMR-based metabolomics

Single-Cell Genomics Deep insights into complex biology

The Hellenic Network of Biobanks-BBMRI-GR Dr. S.Kolyva Representative of Greece in the General Assembly of BBMRI-ERIC

Metabolomics: Techniques and Applications ABRF

Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases

Biomarkers and clinical trials. Patricia woo UCL

Big Data Standards and the Potential Long-Term Benefits for Research and Clinical Development

Transcription:

BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017

BBMRI-NL TOWARDS A NATIONAL BIOBANKING INFRASTRUCTURE Founded in 2009 as the Dutch node within the European BBMRI-ERIC Established to align, connect, complete and enrich biobanks Connecting > 200 Dutch biobanks Innovative integration of complementary efforts involving data, tissue, samples, population imaging and IT for translational research Aims to establish a sustainable nation-wide infrastructure for collecting, managing and providing access to data and samples for cutting-edge translational biomedical research 2

Catalogue with > 200 biobanks ELSI center of expertise Tools & Applications http://www.bbmri.nl 3

Highlights BBMRI-NL molecular data N=100,000 GWAS N=750 Go.NlL N=4,000 N=4,000 N=50,000 N>250,000 BIOS consortium BIOS consortium METABOLITE consortium Building a central database for the research community - To store raw and processed data - Reference data for case-control studies and imputation - Linking to clinical phenotypes 4

Warehouse of data shared and used by the community 26 PAPER S PUBLISHED; 8 IN PREP SCIENCE, NAT GENET(6); NAT COMM (3); GENOME BIOL (3)

Highlights BBMRI-NL Cloud for controlled access multi-center studies Storage & compute infrastructure services (e.g. virtual private cluster facilities at Groningen & Amsterdam) Pipeline services (e.g. imaging, DNA, RNA, metabolomics, microbiome) BIOS Integration and warehouse services (e.g. clinical phenotypes, imaging phenotypes, molecular phenotypes, biobankconnect data harmonization, translational research toolbox) 6

http://www.bbmri.nl/omics/

1H-NMR metabolomics platform Metabolic health ; well-standardized ( 50.000 samples ; 30 cohorts) 8

BBMRI.Nl : 7 Diseases; 22 cohorts; 25.000 Dutch Caucasians Ovelapping (Generic) risk profiles Type 2 Diabetes Preliminary results: Metabolomics markers predict multiple diseases And mortality Generic profiles of health Cardiovascular Disease Osteoarthritis Dementia Metabolome N=25.000 Ageing Mortality Depression Migraine 9

Metabolic Health or age scores ; compare to traditional markers; multiple sampling 10 Corbel Brussel 20

Risk assessment; Monitoring; Understanding What does the Metabolome reflect: 11 Preliminary results: Metabolomics markers in blood associate to CVD/T2D, response to intervention and android fat in DEXA Corbel Brussel 20

Combining with e-health, monitoring the vital lifecourse Public domain -> primary & secondary care at home/home care 12 Corbel Brussel 20

Highlights BBMRI-NL imaging data Building a population imaging infrastructure - Pool existing image data and generate new data - Central database to store raw and processed data - Procedures to harmonize data - Development of reference data for case-control studies, spanning wide age range - Linking image data to clinical and molecular phenotypes 13

Medical Research Profile LUMC : link biomed/epi/clinical studies at LUMC Neuro-cardiovascular Musculoskeletal CLASSIFICATION BIOMARKERS SPECIFIC AND GENERIC NON-INVASIVE (SERUM, MRI) UNDERSTANDING METABOLIC HEALTH HETEROGENEITY BEYOND BLOOD Immune /Metabolic Health Biological age INTERVENTIONS MONITORING LIFESTYLE/CLINIC HETEROGENEOUS RESPONSES 14

Highlights BBMRI-NL access to archival tumor material 12 million tissue samples stored in pathology archives 42 million records on almost 10 million patients stored in the central data- bank 15

Highlights BBMRI-NL public access to BBMRI generated knowledge via APPS Apps for the clinic Apps for researchers Apps for the public

Thank you on behalf of the BBMRI-NL partners 17